<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02345681</url>
  </required_header>
  <id_info>
    <org_study_id>RC14_0268</org_study_id>
    <nct_id>NCT02345681</nct_id>
  </id_info>
  <brief_title>Impact of Rational Control of Fluid Balance in the Intensive Care Unit</brief_title>
  <acronym>IRIHS-REA</acronym>
  <official_title>Impact of Rational Control of Fluid Balance in the Intensive Care Unit.IRIHS-REA</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <brief_summary>
    <textblock>
      Patients admitted in the Intensive Care Unit (ICU) frequently display and excessive fluid&#xD;
      balance over a very short period of time. This positive fluid balance is the consequence of&#xD;
      different organ failures (pulmonary, cardio-vascular, kidney…) or aggressive fluid&#xD;
      resuscitation, which is mandatory in the early phase of ICU course. However recent data&#xD;
      strongly suggest that an excessive fluid balance could be detrimental per se (increase of ICU&#xD;
      morbidity or even mortality). There are controversies regarding the potential benefit of&#xD;
      controlling this fluid balance with diuretics which are commonly used worldwide in various&#xD;
      indications (acute and chronic heart failure, chronic kidney failure). In the ICU literature&#xD;
      data are lacking, regarding the possible advantages and drawbacks of diuretics in this&#xD;
      indication. The aim of our study is to test an algorithm with furosemide to reduce fluid&#xD;
      overload in severe ICU-patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2015</start_date>
  <completion_date type="Actual">April 2019</completion_date>
  <primary_completion_date type="Actual">April 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evolution of fluid balance between randomisation and extubation (fluid balance in our study = Patient's weight at randomisation - Patient's initial weight (Kg) defined as the weight at admission)</measure>
    <time_frame>Day 60</time_frame>
    <description>Definition of fluid balance in our study = Patient's weight at randomisation - Patient's initial weight (Kg) defined as the weight at admission</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of ventilatory-free days</measure>
    <time_frame>Day 28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of ICU-free days</measure>
    <time_frame>Day 60</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Period of mechanical Ventilation</measure>
    <time_frame>Day 60</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Extubation Failure</measure>
    <time_frame>Day 60</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU Period of stay</measure>
    <time_frame>Day 60</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">171</enrollment>
  <condition>Fluid Balance of ICU Patients</condition>
  <condition>Fluid Overload</condition>
  <arm_group>
    <arm_group_label>Test Furosemide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>We will test our furosemide algorithm in one arm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Classical Strategy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>It's a classical strategy without diuretics</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Furosemide</intervention_name>
    <arm_group_label>Test Furosemide</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age of 18 or more&#xD;
&#xD;
          -  Patients receiving endo-tracheal intubation and mechanical ventilation during their&#xD;
             stay in the ICU&#xD;
&#xD;
          -  Weight increase of at least 3 % during the stay. Baseline weight is regarded as the&#xD;
             weight at the 24th hour after ICU admission&#xD;
&#xD;
          -  FiO2 &lt; 60 %, PEEP &lt; 10cmH20&#xD;
&#xD;
          -  No administration of catecholamines other than dobutamine at a dose of 10&#xD;
             microg.Kg-1.min-1&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Patient with a moribund state at ICU arrival&#xD;
&#xD;
          -  Acute brain injury (traumatic brain injury, subarachnoid hemorrhage, intra-cerebral&#xD;
             bleeding, stroke, meningo-encephalitis, coma from medication origin)&#xD;
&#xD;
          -  Chronic kidney disease defined as creatinin clearance &lt; 30mL.min-1 and/or with chronic&#xD;
             dialysis&#xD;
&#xD;
          -  Mandatory administration of diuretics (cardiogenic pulmonary oedema, LVEF &lt; 30 %)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karim Asehnoune</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Nantes</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christine LEBERT</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHD La Roche sur Yon</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital François Mitterand</name>
      <address>
        <city>Dijon</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHD Vendée</name>
      <address>
        <city>La Roche sur Yon</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Nantes</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>January 20, 2015</study_first_submitted>
  <study_first_submitted_qc>January 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 26, 2015</study_first_posted>
  <last_update_submitted>August 9, 2021</last_update_submitted>
  <last_update_submitted_qc>August 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>furosemide</keyword>
  <keyword>under strict conditions</keyword>
  <keyword>normalize</keyword>
  <keyword>ICU patients</keyword>
  <keyword>fluid balance</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Furosemide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

